LAVIPHARM S.A. (CR) financial statements, including revenue, expenses, profit, and loss
The total revenue of LAVI for the last semiannual is 26.31 M EUR, and it's 22.52% higher compared to the previous semiannual. The net income of H1 24 is 7.74 M EUR.